Elon Musk has voiced concerns about the future stability of the U.S. dollar, highlighting the escalating national debt as a potential catalyst for a looming economic crisis. Continue Reading ➔
Not long ago trading legend Jim Fink revealed how he turns stock moves as small as 1% into gains of 108%, 118%, and even 163% in as little as three days. His program is so powerful — and easy-to-follow — anyone who uses it will have the opportunity to see gains of 5,000% in the next 12 months alone. Get the details here now.
Renowned economist Mohamed El-Erian shared a comprehensive table of financial returns for major assets and asset classes, highlighting the volatility of the market in April. Continue Reading ➔
NEW YORK (AP) — It’s never fun to be scammed, but if you’re a small business owner then falling for a scam can have long-lasting effects on a business, damaging client relationships and profit. Continue Reading ➔
One little-known coin is quietly gearing up for a potential breakout. Our analysts believe it could be the surprise crypto hit of 2024. Discover the name of this under-the-radar gem and our full analysis for just $3. Learn more
The 2024 election is viewed as closely contested at this stage, with no clear lead emerging, but historical trends suggest a likely winner. Continue Reading ➔
Investing in stocks under $10 could increase the returns on your portfolio, especially if you pick the right stocks. Within this report you will find 5 top stocks that offer the best bang for the buck. Add them to your watchlist before they take off!
Cramer, a prominent figure in the finance world, suggested that investors should not emulate the trading habits of large hedge funds. Instead, he recommended a long-term investment strategy, emphasizing the need to anticipate and endure market declines. Continue Reading ➔
Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029. Continue Reading ➔
Amazon has just made a stunning $144 million investment in one small AI company. Why? Because this under-the-radar firm holds the key to unleashing the full potential of next-gen AI… Its technology is crucial for the most advanced AI chips, including Nvidia’s latest breakthrough. Discover why
Results from the Phase 3 SOLARIS trial of TEV-‘749 for schizophrenia treatment. SteadyTeq technology ensures controlled olanzapine release. Clinically meaningful improvements in PANSS scores observed across dosing groups. Continue Reading ➔
The fading sway of Trump in motor sports suggests the breakup of the conservative-racing connection, as shown by recent developments at the Miami Grand Prix. Continue Reading ➔
DENVER (AP) — Frontier Airlines, which has struggled more than other U.S. carriers to , says it is eliminating change fees on some tickets and creating four fare classes to boost its appeal to more travelers. Continue Reading ➔
A new 2024 election poll shows a close race between Donald Trump and Joe Biden. One candidate gained ground with their party and Independent voters. Continue Reading ➔
WASHINGTON (AP) — President Joe Biden’s campaign and Democratic candidates are in a fevered race with Republicans over who can best exploit the potential of artificial intelligence, a technology that could transform American elections — and perhaps threaten democracy itself. Continue Reading ➔
Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.
